⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of ScreenSYS GmbH and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
ScreenSYS GmbH
↗Freiburg, Germany
ScreenSYS GmbH is a green biotechnology company based in Freiburg, Germany, that specializes in digital in vitro plant breeding solutions. The company has developed a unique, AI-powered, automated platform that industrializes the generation of Doubled Haploid (DH) plants from single plant cells, significantly accelerating the breeding cycle for various crops.
By utilizing algorithms and patented cell handling technology, ScreenSYS enables breeders to overcome traditional bottlenecks and recalcitrance in plant species. Their technology is designed to be plant-agnostic, facilitating the rapid development of superior traits—such as climate resilience and improved nutritional content—across a wide range of agricultural, ornamental, and medicinal plant species.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Biotechnology
Sub-Industry:Agricultural Biotechnology
SIZE & FINANCIALS
Employees:1-50
Founded:2016
Ownership:private
Status:operating
FUNDING
Stage:Seed
PIPELINE
Stage:Commercial
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Works with global plant breeders to implement AI-driven DH technology
COMPETITION
Position:Emerging
Competitors:Melonfrost, Calice, IBP
LEADERSHIP
Key Executives:
Oleksandr Dovzhenko - Co-Founder & CEO
Klaus Palme - Co-Founder & CSO
Klaus Nitschke - Co-Founder & Advisor
Scientific Founders:Oleksandr Dovzhenko, Klaus Palme
LINKS
Website:screensys.de
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with ScreenSYS GmbH. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.